Dr. Gregory Barton's research lab at UC Berkeley is focused on understanding how the immune system differentiates between self and non-self nucleic acids to prevent autoimmune diseases. His team studies Toll-like receptors (TLRs), especially TLR7 and TLR9, which are critical in regulating immune responses. They are exploring how specific proteins and external signals affect these receptors' functions, with the goal of developing better therapies for autoimmune conditions and enhancing tissue repair processes.

Dr. Susan Landau's lab at UC Berkeley focuses on how lifestyle changes like diet, exercise, and cognitive stimulation can help protect brain health and reduce the risk of conditions like Alzheimer's disease in older adults. They are conducting research within the POINTER study, which aims to see if a structured lifestyle intervention has measurable effects on brain health over two years. The lab uses advanced imaging techniques to explore how these interventions impact brain biomarkers associated with dementia.

Dr. Gloria Ann Brar's lab focuses on understanding how cells rejuvenate their protein components during the formation of gametes, which are essential for sexual reproduction. By studying the simple budding yeast, they aim to identify the key proteins that are reset to maintain their youthfulness, even when derived from older cells. This research could provide insights into aging and new strategies to combat age-related cellular damage.

Dr. Lydia L. Sohn's lab at UC Berkeley explores the mechanical properties of breast epithelial cells to understand breast cancer susceptibility. The lab combines cutting-edge technology to measure how these properties change with age and genetic risk factors. By developing a novel platform called mechano-NPS, they aim to improve breast cancer detection methods beyond traditional genetic testing.

Dr. F. Dean Toste's lab at UC Berkeley focuses on creating new methods for synthesizing organic compounds that can be used in medicine. The lab mainly develops new reactions using special catalysts to construct important chemical bonds, particularly those involving fluorine. Researchers also investigate how non-covalent interactions influence chemical selectivity, aiming to improve tools for chemists and biomedical researchers.

The Cate lab at UC Berkeley studies how protein synthesis, or translation, is regulated in humans. They focus on a special protein called eIF3 that controls how and when specific messenger RNAs are translated into proteins. This research is important because it can lead to new methods for treating diseases by better understanding translation control and developing new drugs targeting difficult-to-target proteins.

David G Drubin's lab at UC Berkeley focuses on understanding how cells take in materials and interact with their environment, particularly through a process called clathrin-mediated endocytosis (CME). They study this process in both yeast and human stem cells, using advanced imaging techniques to look at the proteins involved and how they function together. Their research aims to uncover the mechanisms behind how cells differentiate and respond under various conditions, which could have implications for understanding diseases and developing treatments.

Dr. Steven Conolly's lab at UC Berkeley is focused on advancing a new imaging technology called Magnetic Particle Imaging (MPI). This technology aims to provide rapid, non-invasive imaging without radiation, crucial for monitoring treatments like CAR-T immunotherapy and diagnosing conditions like strokes and pulmonary embolisms. By improving the spatial resolution of MPI, the lab seeks to enhance medical imaging capabilities significantly, making diagnoses faster and safer.

Dr. Hedy Kober's lab at UC Berkeley focuses on understanding the brain markers related to cravings and substance use disorders, which are crucial for developing better treatments. The lab uses advanced brain imaging techniques and machine learning to analyze how the brain responds to different substances, with the aim of creating reliable tests to predict cravings and relapses in individuals with substance use issues. By studying large groups of individuals from various backgrounds, the lab seeks to enhance the effectiveness of therapies for addiction.

Dr. Joni D Wallis's lab at UC Berkeley explores how specific brain areas, particularly the orbitofrontal cortex and caudate nucleus, influence decision-making processes. By investigating the dynamics between these regions during flexible and habitual behaviors, the lab aims to uncover how dysfunction in these circuits can lead to neuropsychiatric disorders like OCD and addiction. The research employs advanced techniques like closed-loop microstimulation to better understand the neuronal mechanisms behind learning and decision-making.

Dr. Daniel Feldman's research lab at UC Berkeley focuses on understanding how certain brain cells, called inhibitory interneurons, regulate their activity in response to sensory experiences and learning. The lab investigates how these changes may play a role in conditions like autism, particularly looking at molecular mechanisms and plasticity in different types of interneurons. By studying how these cells can adapt in the somatosensory cortex, the research aims to uncover new therapeutic targets for improving brain function in autism and similar disorders.

Dr. Iswar K. Hariharan's lab at UC Berkeley focuses on understanding how growth is regulated in living organisms, particularly through studying the development and regeneration of structures in fruit flies (Drosophila). By examining the genetic mechanisms involved during both normal growth processes and regenerative growth after injury, the lab seeks to uncover the critical interactions between different cell types. This research is vital for gaining insights into various medical conditions, including cancer and birth defects, which are influenced by growth abnormalities.

Dr. Allison G Harvey's lab focuses on understanding and improving sleep and circadian functioning in midlife and older adults, as well as in adolescents with evening chronotypes (night-owls). The lab investigates innovative treatments that enhance patient memory for sleep interventions to boost treatment adherence and outcomes. They also explore habit-based interventions to promote better sleep health behaviors among youth, particularly targeting those at risk for various health complications.

Professor Ian H. Holmes leads a research lab at UC Berkeley focusing on developing user-friendly bioinformatics tools for genomic analysis. The lab works on enhancing the GMOD suite, specifically JBrowse, to make genome annotations and analysis more accessible to biologists. Their innovative approaches include machine learning features to assist users in navigating complex genomic datasets and user-friendly design improvements.

Professor John F. Hartwig's lab at UC Berkeley focuses on developing innovative chemical reactions that are essential for creating new medications. The lab works with transition metals to discover new catalysts that can streamline the production of important organic compounds, particularly those that target specific parts of complex molecules. This research aims to deepen our understanding of how these catalysts operate, leading to more effective and efficient synthetic methods in medicinal chemistry.

Maria V. Ivanova's research lab focuses on how high-intensity exercise can help improve language and cognitive skills in individuals who have experienced strokes and suffer from aphasia. By combining physical training with innovative therapies, the lab aims to create new rehabilitation strategies that address not just speech but also overall well-being and brain health in stroke survivors.

The research lab of Dr. Richard Ivry at UC Berkeley focuses on understanding the cerebellum and its significant role in various cognitive processes beyond just movement control. The lab investigates how the cerebellum contributes to tasks such as perception, attention, and decision-making by conducting behavioral experiments and neuroimaging studies. They also study patients with cerebellar disorders to better understand cognitive impairments related to cerebellar function.

Dr. William J. Jagust's lab focuses on understanding how the blood-brain barrier (BBB) and Alzheimer's disease (AD) pathology are connected. The research investigates how changes in the BBB function can lead to cognitive decline and AD, aiming to clarify the sequence of events that trigger the disease. By combining advanced imaging techniques in humans with experiments in mouse models, the lab seeks to unravel the mechanisms linking BBB disruption with protein deposits related to AD.

Dr. Amy J. Pickering's lab focuses on improving maternal and neonatal health in sub-Saharan Africa by addressing water quality and hygiene in rural health facilities. They have developed an innovative, low-cost chlorination technology that disinfects water automatically, aiming to reduce infections that threaten newborns and mothers. The lab conducts rigorous trials to assess the effectiveness of this intervention in improving health outcomes and minimizing antibiotic resistance.

Dr. Stephan Lammel's lab at UC Berkeley explores how certain brain systems influence behaviors related to reward and feeding. Using advanced techniques like optogenetics and fiber photometry, they investigate dopamine neurons and their role in learning and motivation. The lab's research has potential implications for treating disorders such as addiction and obesity by understanding how neural circuits operate in different contexts.